Sertraline is indicated for the treatment of the following disorders : Major depressive episodes. Preventing the recurrence of major depressive episodes. Panic disorders with or without agoraphobia. Obsessive-compulsive disorder (OCD) in adults and children aged 6-17 years. Social anxiety disorder. Post-traumatic stress disorder (PTSD).
Composition and form of release
The active component of this pharmaceutical is sertraline 100 mg. Serlift’s release form is tablets.
The drug Serlift is used to treat and prevent relapse of depressive conditions (from mild to severe), including those that are accompanied by the risk of a suicidal attempt, anxiety.
Also, this drug is indicated for PTSD (post-traumatic stress disorder), OCD (obsessive-compulsive disorder), panic disorders (with / without agoraphobia or other phobia), anorexia nervosa, chronic pain syndromes, bulimia.
Surlift should not be used in case of hypersensitivity to it, epilepsy (with exacerbation), children under six years old, pregnant women, breastfeeding.
It is also prohibited to take the drug Serlift and MAO inhibitors at the same time.
Application during pregnancy and lactation
The use of the drug Serlift during the indicated periods is prohibited.
Method of administration and dosage
The starting standard dose of this drug is 50 mg / day in one dose. The remedy is obtained regardless of food.
The initial effect can be seen as early as seven days after starting therapy, but the full effect of this drug usually appears after two to four weeks. If there is no effect after several weeks from the start of therapy, you can gradually increase the dose (by 50 mg per week); the maximum dose of Surlift is 200 mg / day.
With long-term therapy, the patient must individually select the minimum effective maintenance dose.
Surlift should not be used in conjunction with drugs of the MAO inhibitor group and within fourteen days after stopping treatment with them. Similarly, after canceling Surlift, MAO inhibitors should not be taken for fourteen days.
Symptoms of a Surlift overdose include: disorientation, anxiety, tremors, restlessness, muscle hypertonicity, dilated pupils, increased reflexes, abdominal cramps, increased heart rate, myoclonic twitching, drowsiness, flatulence, nausea, diarrhea, vomiting, dyspepsia.
In the first hour in case of an overdose with Serlift, gastric lavage should be performed, then adsorbents should be given. Further, it is required to ensure the patient’s airway patency. Control of the functions of vital organs is necessary; symptomatic treatment is indicated. There is no specific antidote.
When using Serlift, the patient may experience allergic reactions, decreased appetite, the development of bleeding (nasal, etc.), weight loss, increased appetite (rare), the occurrence of nausea, hypomania and mania, palpitations, dry mouth, vomiting, diarrhea , abdominal pain and cramps, flatulence, headache, dizziness, insomnia, drowsiness, tremors, coordination disorders (including gait changes, etc.), seizures, paresthesias, hallucinations, aggressiveness, agitation, anxiety, psychosis, flushing face, visual impairment, hyperhidrosis (increased sweating), sexual dysfunctions (decreased potency, anorgasmia, etc.), dysmenorrhea, galactorrhea (secretion of breast milk not associated with breastfeeding), skin rashes, itching.
Also, the development of a withdrawal syndrome is among the undesirable phenomena associated with taking the drug Serlift.
Storage conditions and periods
Serlift is stored at temperatures below + 25 ° C in a dry place.
The shelf life of Serlift tablets is three years.